Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Research by New Jersey Vascular Doctor, Lowell S. Kabnick, M.D., Finds Inequality in Health Insurance Policies
  • USA - English


News provided by

Paramount/MD

Aug 21, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Lowell Kabnick, MD
Lowell Kabnick, MD
Vimeo
Vimeo

Morristown, NJ (PRWEB) August 21, 2014 -- Lowell S. Kabnick, MD, a practicing vascular doctor in New Jersey, has uncovered significant inequalities in health insurance guidelines governing coverage of treatment for symptomatic varicose veins. Dr. Kabnick, whose study appears in the current issue of the medical journal Phlebology, aims to draw attention to the issue and encourage policy reform amongst the nation’s health insurance providers.

Both patients and vascular physicians are increasingly frustrated, and certainly ill-served, by the clear lack of consistency in the way insurance providers are creating their policy rules for varicose vein treatment.

Post this

Dr. Kabnick, who founded the first vein treatment center in New Jersey exclusively dedicated to treating vein problem and vascular disease, has long been a patient advocate intent on educating the public and pushing for progress among physicians and other arms of health care, including insurance. He conducted his recent study, titled Inequalities of health insurance guidelines for the treatment of symptomatic varicose veins, after noticing marked differences in coverage for vein treatment. “Patients who suffer from the painful symptoms of varicose veins should be able to seek appropriate medical treatment for their condition, and to have their treatment covered by insurance on the basis of consistent, medically supported guidelines,” said Dr. Kabnick.

In the study, Dr. Kabnick and his colleagues analyzed the medical policies of several US health insurers to determine if carriers used evidence-based medicine to create consistent policies for the treatment of patients with symptomatic varicose veins. The study findings reveal a dramatic lack of uniformity among insurance policies, in addition to examples of frequent modification of rules regarding medical necessity, and rising frustration levels among patients and their providers.

“Both patients and vascular physicians are increasingly frustrated, and certainly ill-served, by the clear lack of consistency in the way insurance providers are creating their policy rules for varicose vein treatment,” said Dr. Kabnick. “This issue deserves attention, and patients and providers deserve equitable rules and treatment.”

Whether insurance providers will implement changes to their current policy guidelines is uncertain. But Dr. Kabnick is certainly determined to shine a light on this troubling issue and to continue to push for progress.

For more information, visit: http://www.lowellkabnickmd.com/.

The online version of Dr. Kabnick’s article can be found at: http://phl.sagepub.com/content/29/4/236.

-----
Varicose Vein Treatment Options

Up to 30 million people in the United States suffer from spider veins and varicose veins, which means they are quite a common affliction. Women tend have vein problems more often than men; however both genders are affected. Varicose veins are large, twisting, blue or red veins that stand out or bulge from the surface of the skin, while spider veins are smaller, web-like veins that may look reddish and tangled.

Fortunately, a number of safe, minimally invasive and highly effective vein treatments are now available. They include radiofrequency ablation, microphlebectomy, and sclerotherapy, among others. These techniques help restore the health and beauty of the legs by eliminating or removing varicose veins and spider veins, with a minimum of pain, scarring and recovery time.

----
About Lowell S. Kabnick

In 1986, Dr. Lowell S. Kabnick, MD, RPhS, FACS, PFACPh, founded the first vein treatment center in New Jersey exclusively dedicated to treating vein problem and vascular disease. The center is now recognized as a world leader in vein disease treatment. Dr. Kabnick himself is a pioneer in the development of minimally invasive vein disease treatments that allow patients to restore the health and beauty of their legs with minimal discomfort and practically no downtime.

Dr. Kabnick devotes his practice entirely to venous diagnosis and treatments. He is recognized as one of the area’s Top Doctors and he has written a book series entitled “Practical Phlebology,” a reference book for vascular doctors. Dr. Kabnick joined the NYU faculty in 2007 as Director of the NYU Vein Center, and he is known as an international authority on the diagnosis and treatment of vein disease.

Dr. Kabnick and his staff offer the VNUS closure procedure, VenaCure EVLT (endovenous laser treatment), and phlebectomy and microphlebectomy. Patients can schedule their procedures at either the Morristown, NJ office or in New York City at the NYU vein center. Patients are assured of the high level of patient care you expect from physicians who train other vascular doctors from all over the world.

Lowell S. Kabnick
Tel: (973) 453-2186
http://www.lowellkabnickmd.com/

Christine Sirgado, Paramount/MD, http://paramountmd.com, +1 415-413-2170, [email protected]

Modal title

Director of the NYU Vein Center
Director of the NYU Vein Center
Medical Director
Medical Director
Director of the NYU Vein Center Medical Director

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.